DigitalGlobe Stock Falls On Unusually High Volume (DGI)

NEW YORK ( TheStreet) -- DigitalGlobe (NYSE: DGI) is trading at unusually high volume Wednesday with 1.3 million shares changing hands. It is currently at 4.3 times its average daily volume and trading down $2.88 (-16.7%) at $14.38 as of 12:10 p.m. ET.

DigitalGlobe has a market cap of $753.7 million and is part of the technology sector and computer software & services industry. Shares are up 0.9% year to date as of the close of trading on Tuesday.

DigitalGlobe, Inc. provides commercial earth imagery products and solutions. The company collects its imagery products and services via its three high-resolution imagery satellites. The company has a P/E ratio of 568.7, below the average computer software & services industry P/E ratio of 814.5 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates DigitalGlobe as a hold. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, disappointing return on equity and weak operating cash flow. You can view the full DigitalGlobe Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

Interested in other stocks that are falling on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVDOWN to 95370 or select from multiple alert options.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing